Del. Jury Finds Kurin Infringed Rival's Blood-Testing Patent

By Dorothy Atkins (July 26, 2022, 9:16 PM EDT) -- A Delaware federal jury found Tuesday that Kurin Inc.'s blood-testing products infringe Magnolia Medical Technologies Inc.'s blood-testing patent in the first phase of the two-part jury trial, sending the case to a second trial to determine the amount Kurin owes in damages for the infringement....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!